InVitro International, Inc.

OTCPK:IVRO Stock Report

Market Cap: US$2.1m

InVitro International Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Rich Ulmer

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure30.2yrs
CEO ownershipn/a
Management average tenure30.2yrs
Board average tenure30.5yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Rich Ulmer (81 yo)

30.2yrs

Tenure

US$139,518

Compensation

Mr. W. Richard Ulmer, also known as Rich, has been Chief Executive Officer, President and Director of Invitro International since November 15, 1994. Mr. Ulmer started his career in the health care and phar...

Leadership Team

NamePositionTenureCompensationOwnership
W. Ulmer
CEO, President & Director30.2yrsUS$139.52kno data
Dennis Chenoweth
Senior Vice President and Director29.4yrsUS$125.85kno data
Cathy Richmond
CFO & Directorno datano datano data
William Curtis
Executive Officer39.3yrsno datano data

30.2yrs

Average Tenure

81yo

Average Age

Experienced Management: IVRO's management team is seasoned and experienced (30.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
W. Ulmer
CEO, President & Director30.2yrsUS$139.52kno data
Dennis Chenoweth
Senior Vice President and Director29.4yrsUS$125.85kno data
Cathy Richmond
CFO & Directorno datano datano data
William Curtis
Executive Officer39.3yrsno datano data
Irwin Gruverman
Chairman of the Board31.8yrsno datano data
David Reed
Director28.4yrsno datano data
Jeffrey Safchik
Director30.8yrsno datano data
Sean Adrean
Directorno datano datano data
Steven Pitassi
Directorno datano datano data

30.5yrs

Average Tenure

82yo

Average Age

Experienced Board: IVRO's board of directors are seasoned and experienced ( 30.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 06:46
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InVitro International, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution